Compound Profile: Stanorox
Stanorox 50mg Zerox is a synthetic anabolic steroid derived from dihydrotestosterone, specifically designed for in-vitro laboratory research applications. This compound represents a modified derivative of testosterone, engineered with structural modifications that researchers investigate for its unique molecular properties. The 50mg formulation provides researchers with precise quantities suitable for controlled analytical studies. Each tablet contains pharmaceutical-grade stanozolol manufactured by Zerox Pharmaceuticals, ensuring consistent purity levels for reliable experimental outcomes. Research facilities examining anabolic compounds often utilise this formulation due to its standardised potency and reproducible characteristics. At Stroid UK Shop, we supply this research material exclusively for laboratory investigation purposes, supporting the scientific community’s ongoing studies into synthetic hormone analogues.
Laboratory Applications
Research scientists investigate Stanorox 50mg Zerox across multiple analytical frameworks, examining its molecular structure and biochemical properties. Studies focus on its anabolic-to-androgenic ratio, exploring how structural modifications affect receptor binding affinity. Researchers analyse its metabolic pathways, investigating hepatic processing and elimination kinetics in controlled laboratory environments. The compound’s stability under various storage conditions provides valuable data for pharmaceutical research teams studying synthetic steroid preservation. Academic institutions examining stanozolol compounds utilise this formulation for comparative analysis against other anabolic agents. Research applications extend to analytical chemistry studies, where scientists evaluate detection methods and chromatographic separation techniques. The standardised 50mg concentration facilitates dose-response relationship studies in laboratory settings. Comparative research with selective androgen receptor modulators provides insights into different mechanistic approaches to androgen receptor activation. Additionally, researchers studying peptide-based compounds often use stanozolol as a reference standard for anabolic activity comparisons.
Technical Specifications
| Active Compound | Stanozolol |
|---|---|
| Concentration | 50mg per tablet |
| Package Size | 100 tablets |
| Manufacturer | Zerox Pharmaceuticals |
| CAS Number | 10418-03-8 |
| Molecular Formula | C21H32N2O |
| Molecular Weight | 328.49 g/mol |
| Storage Conditions | Room temperature, dry environment |
Research Compliance
Stanorox 50mg Zerox is manufactured exclusively for in-vitro research applications and analytical studies. This product is not intended for human consumption, therapeutic use, or any form of in-vivo application. Researchers must maintain appropriate laboratory protocols and safety measures when handling this compound. All studies must comply with institutional research guidelines and applicable regulatory frameworks governing synthetic hormone research materials.
